CSP updates guidance on platelet-rich plasma (PRP) therapy
The CSP has resolved uncertainties around the legal and regulatory status of platelet-rich plasma (PRP) therapy through discussions with the Medicines and Healthcare products Regulatory Agency (MHRA).
New community care report is a 'wake-up call' for the government, says CSP
The health and care system in England must shift its focus away from hospital care to primary and community services if it is to be effective and sustainable, according to a new report published by the King’s Fund this week.